Nitinotes Expands U.S. Obesity Trial at Weill Cornell Center
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
Redwood City, California, August,11, 2026 Galvanize Therapeutics, Inc. has announced the completion of the first commercial procedures using its...
